76
Views
0
CrossRef citations to date
0
Altmetric
Musculoskeletal

Vitamin D levels in idiopathic inflammatory myopathy patients: a meta-analysis

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 141-149 | Received 25 Sep 2023, Accepted 26 Feb 2024, Published online: 04 Mar 2024

References

  • Mandel D, Malemud C, Askari A. Idiopathic inflammatory myopathies: a review of the classification and impact of pathogenesis. Int J Mol Sci. 2017;18(5):1084. doi: 10.3390/ijms18051084
  • Rothwell S, Chinoy H, Lamb JA. Genetics of idiopathic inflammatory myopathies: insights into disease pathogenesis. Curr Opin Rheumatol. 2019;31(6):611–616. doi: 10.1097/BOR.0000000000000652
  • Zhu H, Zhang L, Zhou B, et al. The role of immune cells in the pathogenesis of idiopathic inflammatory myopathies. Aging Dis. 2021;12(1):247. doi: 10.14336/AD.2020.0410
  • Iolascon G, Paoletta M, Liguori S, et al. Neuromuscular diseases and bone. Front Endocrinol. 2019;10:10. doi: 10.3389/fendo.2019.00794
  • Mok CC. Vitamin D and systemic lupus erythematosus: an update. Expert Rev Clin Immunol. 2014;9(5):453–463. doi: 10.1586/eci.13.19
  • Etten E, Mathieu C. Immunoregulation by 1,25-dihydroxyvitamin D3: Basic concepts. J Steroid Biochem Mol Biol. 2005;97(1–2):93–101. doi: 10.1016/j.jsbmb.2005.06.002
  • Perwad F, Portale AA. Vitamin D metabolism in the kidney: regulation by phosphorus and fibroblast growth factor 23. Mol Cell Endocrinol. 2011;347(1–2):17–24. doi: 10.1016/j.mce.2011.08.030
  • Prietl B, Treiber G, Pieber T, et al. Vitamin D and Immune Function. Nutrients. 2013;5(7):2502–2521. doi: 10.3390/nu5072502
  • Yu Z, Cheng H, Liang Y, et al. Decreased serum 25-(OH)-D level associated with muscle enzyme and myositis specific autoantibodies in patients with idiopathic inflammatory myopathy. Front Immunol. 2021;12:12. doi: 10.3389/fimmu.2021.642070
  • Xu Y, Baylink DJ, Chen C-S, et al. The importance of vitamin d metabolism as a potential prophylactic, immunoregulatory and neuroprotective treatment for COVID-19. J Transl Med. 2020;18(1). doi: 10.1186/s12967-020-02488-5
  • Cutolo M. Further emergent evidence for the vitamin D endocrine system involvement in autoimmune rheumatic disease risk and prognosis. Ann Rheumatic Dis. 2013;72(4):473–475. doi: 10.1136/annrheumdis-2012-202538
  • Liu W, Li H, Hao Y, et al. Decreased immunosuppressive actions of 1α, 25-dihydroxyvitamin D3 in patients with immune thrombocytopenia. Mol Immunol. 2016;78:89–97. doi: 10.1016/j.molimm.2016.08.014
  • Bittenbring JT, Neumann F, Altmann B, et al. Vitamin D deficiency impairs rituximab-mediated cellular cytotoxicity and outcome of patients with diffuse large B-Cell lymphoma treated with but not without Rituximab. J Clin Oncol. 2014;32(29):3242–3248. doi: 10.1200/JCO.2013.53.4537
  • Bohan A, Peter JB. Polymyositis and dermatomyositis. N Engl J Med. 1975;292(7):344–347. doi: 10.1056/NEJM197502132920706
  • Aggarwal R, Naveen R, Thakare D, et al. Retinal changes in patients with idiopathic inflammatory myopathies: a case-control study in the MyoCite cohort. Front Med. 2022;9. doi: 10.3389/fmed.2022.1065960
  • Somjen D, Posner GH, Weisman Y, et al. Less-calcemic vitamin D analogs enhance creatine kinase specific activity and modulate responsiveness to gonadal steroids in rat skeletal tissues. J Endocrinol Invest. 2014;30(2):91–96. doi: 10.1007/BF03347405
  • Azali P, Barbasso Helmers S, Kockum I, et al. Low serum levels of vitamin D in idiopathic inflammatory myopathies. Ann Rheumatic Dis. 2013;72(4):512–516. doi: 10.1136/annrheumdis-2012-201849
  • Hintzpeter B, Scheidt-Nave C, Müller MJ, et al. Higher prevalence of vitamin D deficiency is associated with immigrant background among children and adolescents in Germany. J Nutr. 2008;138(8):1482–1490. doi: 10.1093/jn/138.8.1482
  • Baeke F, Takiishi T, Korf H, et al. Vitamin D: modulator of the immune system. Curr Opin Pharmacol. 2010;10(4):482–496. doi: 10.1016/j.coph.2010.04.001
  • Ferreira GB, van Etten E, Verstuyf A, et al. 1,25-Dihydroxyvitamin D 3 alters murine dendritic cell behaviour in vitro and in vivo. Diabetes Metabolism Res. 2011;1(8):933–941. doi: 10.1002/dmrr.1275
  • Wing K, Onishi Y, Prieto-Martin P, et al. CTLA-4 control over Foxp3 + regulatory T cell function. Science. 2008;322(5899):271–275. doi: 10.1126/science.1160062
  • Fernan de sdeAbreu DA, Eyles D, Féron F. Vitamin D, a neuro-immunomodulator: implications for neurodegenerative and autoimmune diseases. Psychoneuroendocrinology. 2009;34:S265–S277. doi: 10.1016/j.psyneuen.2009.05.023
  • Palmer MT, Lee YK, Maynard CL, et al. Lineage-specific effects of 1,25-dihydroxyvitamin D3 on the development of effector CD4 T cells. J Biol Chem. 2011;286(2):997–1004. doi: 10.1074/jbc.M110.163790
  • Vincze A, Gaál J, Griger Z. Bone health in idiopathic inflammatory myopathies: diagnosis and management. Curr Rheumatol Rep. 2021;23(7). doi: 10.1007/s11926-021-01016-8
  • Weaver CM, Alexander DD, Boushey CJ, et al. Calcium plus vitamin D supplementation and risk of fractures: an updated meta-analysis from the national osteoporosis foundation. Osteoporosis Int. 2015;27(1):367–376. doi: 10.1007/s00198-015-3386-5
  • Barba T, Fort R, Cottin V, et al. Treatment of idiopathic inflammatory myositis associated interstitial lung disease: a systematic review and meta-analysis. Autoimmun Rev. 2019;18(2):113–122. doi: 10.1016/j.autrev.2018.07.013
  • Tsujino I, Ushikoshi-Nakayama R, Yamazaki T, et al. Pulmonary activation of vitamin D3 and preventive effect against interstitial pneumonia. J Clin Biochem Nutr. 2019;65(3):245–251. doi: 10.3164/jcbn.19-48

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.